Back
Palisade Bio 10K Form
Sell
41
PALI
Palisade Bio
Last Price:
6.20
Seasonality Move:
-12.73%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive PALI News And Ratings
See the #1 stock for the next 7 days that we like better than PALI
PALI Financial Statistics
Sales & Book Value
| Annual Sales: | $250K |
|---|---|
| Cash Flow: | $-2.75M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $18.30 |
| Price / Book: | 0.48 |
Profitability
| EPS (TTM): | -27.15000 |
|---|---|
| Net Income (TTM): | $-12.3M |
| Gross Margin: | -- |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Palisade Bio Earnings Forecast
Key Palisade Bio Financial Ratios
- The Research & Development expenses have been 2,757.20% of Revenue.
- The Interest Expense is -0.12% of Operating Income.
- The Net Earning history of PALI is -4,920.00% of Total Revenues.
- Per Share Earnings over the last 4 years have been positive in 3 years.
Palisade Bio Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | PALI |
| Website: | palisadebio.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
PALI Technical Analysis vs Fundamental Analysis
Sell
41
Palisade Bio (PALI)
is a Sell
Is Palisade Bio a Buy or a Sell?
-
Palisade Bio stock is rated a Sell
The current Palisade Bio [PALI] share price is $6.35. The Score for PALI is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.